Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hernán Tala"'
Autor:
René Díaz, José Miguel Domínguez, Hernán Tala, Roberto Olmos, Pedro Pineda, Daniela Olivarí, Marcela Jiménez, Ximena Mimica, Alejandra Lanas, Gerson Ocares, Jorge Sapunar
Publikováno v:
Archives of Endocrinology and Metabolism (2023)
ABSTRACT Objective: Follicular thyroid carcinoma (FTC) is less frequent but has a worse prognosis than papillary carcinoma. The available evidence on pre-operative characteristics of FTC is controversial. Our objective was to characterize the clinica
Externí odkaz:
https://doaj.org/article/927406f39d0d4ffe8f55fa49bd5ae202
Autor:
Claudio Silva, Eleonora Horvath, Juan Pablo Niedmann, Eliette Castillo, Hernán Tala, Sergio Majlis, Velimir Skoknic, Paulina González, Carolina Whittle
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 30(11)
Background: An important side effect of radioactive iodine (RAI) therapy in patients treated for papillary thyroid cancer (PTC) is chronic sialadenitis. Neck ultrasonography (US) easily recognizes radioiodine-induced salivary gland abnormalities. The
Autor:
Milagros Bracamonte, Elsa Bruce, Marcela Lagos, Antonieta Solar, Félix Vasquez, Naifa L. Busaidy, Miren Osorio, Augusto León, Hernán Tala, René E Díaz, Luis Marín, Tatiana Arias, John Stewart, Emad Kandil, Giovanna Miranda, Jesús Véliz, Alice Tang, Dina Schachter, Eleonora Horvath, Jiang Wang, José Carlos de Miguel Domínguez, Marcela Henríquez, Carmen Franco, Juan Carlos Roa, Paul H. Graham, Mark Zafereo, Hernán E. González, Nicolás Droppelman, Christina S. Kong, Lisa A. Orloff, Maite Lobos, F. Christopher Holsinger, Natalia Mena, Bryan McIver, Patricia Arroyo, Pedro Pineda, Soledad Loyola, David L. Steward, Nelson Wohllk, Francisco Cruz, Michelle A. Williams, Elizabeth G. Grubbs, Eufrosina Traipe, Sergio Vargas-Salas, Francisco Medina
Publikováno v:
Thyroid
Background: Although most thyroid nodules with indeterminate cytology are benign, in most of the world, surgery remains as the most frequent diagnostic approach. We have previously reported a 10-gene thyroid genetic classifier, which accurately predi
Autor:
Soledad Urra, Elsa Bruce, Tatiana Arias, Natalia Mena, Patricia Arroyo, Pedro Pineda, Antonieta Solar, Jesús Véliz, Giovanna Miranda, Luis Marín, Loreto P. Véliz, Manuel Meneses, Hernán E. González, Francisco Cruz, José R Martínez, Eleonora Horvath, Milagros Bracamonte, René E Díaz, Sergio Vargas-Salas, Nelson Wohllk, Soledad Loyola, Eufrosina Traipe, Hernán Tala
Publikováno v:
Thyroid
Background: In most of the world, diagnostic surgery remains the most frequent approach for indeterminate thyroid cytology. Although several molecular tests are available for testing in centralized commercial laboratories in the United States, there
Autor:
Hernán Tala, René E. Díaz, José Miguel Domínguez Ruiz-Tagle, Jorge Sapunar Zenteno, Pedro Pineda, Patricia Arroyo Albala, Marcela Barberán, Patricio Cabané, Francisco Cruz Olivos, Patricio E. Gac, Andrea Glasinovic Pizarro, Hernán E. González, Francisca Grob, Maria Soledad Hidalgo Valle, Rodrigo Jaimovich, Alejandra Lanas, Claudio Liberman, Maite Lobo Guiñez, Arturo Madrid, Marcela Moreno Seguel, Lorena Mosso, Fernando C. Munizaga, Eugenia Ortiz Parada, Fernando Osorio Gonnet, Jeannie Slater Morales, Antonieta Solar, Carlos Stehr, Félix Vásquez Rodríguez, Jesús Véliz, Roberto Villaseca Najarian, Nelson Wohllk
Publikováno v:
Revista médica de Chile v.145 n.8 2017
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection of nodules on ultrasound. The vast majority are benign and asympt
Autor:
Désirée Deandreis, Martin Schlumberger, Eric Baudin, Sophie Leboulleux, Hernán Tala, Steve Larson, R. Michael Tuttle, Marie Terroir, James A. Fagin, Carole Rubino
Publikováno v:
Journal of Nuclear Medicine. 58:717-722
The optimal management of radioactive iodine (RAI) treatment in patients with metastatic thyroid cancer (TC) is still a matter of debate. Methods: We retrospectively analyzed 352 patients with RAI-avid metastatic well-differentiated TC treated with 1
Autor:
Hernán, Tala, René E, Díaz, José Miguel, Domínguez Ruiz-Tagle, Jorge, Sapunar Zenteno, Pedro, Pineda, Patricia, Arroyo Albala, Marcela, Barberán, Patricio, Cabané, Francisco, Cruz Olivos, Patricio, Gac E, Andrea, Glasinovic Pizarro, Hernán E, González, Francisca, Grob, Maria Soledad, Hidalgo Valle, Rodrigo, Jaimovich, Alejandra, Lanas, Claudio, Liberman, Maite, Lobo Guiñez, Arturo, Madrid
Publikováno v:
Revista medica de Chile. 145(8)
The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection of nodules on ultrasound. The vast majority are benign and asympt
Autor:
Fabián, Pitoia, Pitoia, Fabián, Erika, Abelleira, Abelleira, Erika, Hernán, Tala, Tala, Hernán, Fernanda, Bueno, Bueno, Fernanda, Carolina, Urciuoli, Urciuoli, Carolina, Graciela, Cross, Cross, Graciela
Publikováno v:
Endocrine. 46:532-537
To evaluate the outcome of differentiated thyroid cancer (DTC) patients with biochemical persistence of disease (BP) after initial treatment (total thyroidectomy with or without lymph node dissection (LND) and thyroid remnant ablation). BP was define
Autor:
Claudio F Silva, Miguel Domínguez, Juan-Pablo Niedmann, Alex Castro, Eleonora Horvath, Felipe Capdeville, Ricardo Rossi, Ignacio Rodriguez, Arturo Madrid, Hernán Tala, Sergio Majlis, Carolina Whittle, Hugo Rojas, Velimir Skoknic
Publikováno v:
European radiology. 27(6)
To assess performance of TIRADS classification on a prospective surgical cohort, demonstrating its clinical usefulness. Between June 2009 and October 2012, patients assessed with pre-operative ultrasound (US) were included in this IRB-approved study.
Publikováno v:
Thyroid. 21:1317-1322
We previously demonstrated the clinical utility of using response to therapy variables obtained during the first 2 years of follow-up to actively modify initial risk estimates which were obtained using standard clinic-pathologic staging systems. Whil